Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Several Insiders Buy Magnum Hunter Resources Corp (MHR)’s Stock

On Wednesday, two insders at Magnum Hunter Resources Corp (NYSE:MHR) acquired stock from the company. C Gary Evans, Chairman and Chief Executive Officer, bought 30,000 shares: 5,000 of them for $6.06 each, and 25,000 of them, for $6.09 per share. He now holds more than 4.95 million shares, valued at roughly $31.79 million, plus 134,164 shares held indirectly.

L Joe Mcclaugherty, Director of the Board, also purchased stock of the oil and gas exploration small-cap company on Dec. 11th. He acquired 20,000 shares, and paid $6.06 per share for the first 9,900; and $6.08 per share for the remaining 10,100. His holdings now amount to 915,093 shares, worth $5.87 million.

Magnum Hunter Resources Corp (NYSE:MHR)

The transactions occurred on the same date that Magnum Hunter Resources Corp (NYSE:MHR) filed an 8-K form at the U.S. Securities and Exchange Commission announcing an Option Agreement with Pathfinder Onshore Energy Pty Ltd, “a privately held Australian company, granting Pathfinder or its nominee, a subsidiary of New Standard Energy Limited (“NSE”), an Australian Securities Exchange-listed Australian company, an option to acquire Magnum Hunter’s remaining oil and gas properties and related assets in the Eagle Ford Shale in South Texas” (Form 8-K).

However, the purchases did anticipate one important decision that was made public on Thursday, after their purchases: Magnum Hunter Resources Corp (NYSE:MHR)’s Board of Directors approved a capital expenditure budget of $400 million for 2014. In fact, the market reacted quickly to this news, and the stock closed up 5.25% on Thursday’s trading, already providing upside for the insiders who had acquired the stock on Wednesday (interpretation is open related to this matter).

In addition to its CEO and one of its Board Directors, other investors are placing big bets on the company. Robert Henry Lynch’s Aristeia Capital holds 9.3 million shares of Magnum Hunter Resources Corp (NYSE:MHR), valued at more than $57 million. This makes it the largest hedge fund bull, both for the number of shares that it holds and for the percentage of its portfolio allocated to this stock (3.65%).

Among other prominent investors, I would like to highlight Gregory Fraser, Rudolph Kluiber, and Timothy Krochuk‘s Grt Capital Partners, which upped its stakes by 27% over the past quarter, and now holds more than 3 million shares. Finally, there’s George Soros, who owns 2.45 million shares of the company.

So, as bullish sentiment increases from both insiders and hedge funds, should you buy Magnum Hunter Resources Corp (NYSE:MHR)?


Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Why Are These Four Insiders Buying Nuverra Environmental Solutions Inc (NES)’s Stock?

Board Director Invests $1.5 Million in Xencor Inc (XNCR) Amid the IPO

Akamai Technologies, Inc. (AKAM)’s CEO Buys Stock Amid M&A Announcement

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.